Today Research Manitoba and partners are pleased to announce the results of the 2022 Research Manitoba Grants and Awards Competition.
The Children’s Hospital Research Institute of Manitoba is proud to partner on these awards and support the students who will continue their studies in child health research. The full listing of this year’s Grants and Awards Recipients can be found here.
Congratulations to the following recipients who were funded by CHRIM!
Master’s Studentship Competition
SOCIAL/POPULATION HEALTH
Hera Joanna Mariz Casidsid, University of Manitoba, Rady Faculty of Health Sciences, Department of Community Health Sciences (Medicine)
Program: 2022 Master’s Studentship
Funded By: Cost shared with Research Manitoba and Children’s Hospital Research Institute of Manitoba (CHRIM)
Project: The association between the Healthy Baby program and postpartum depression among women in
Manitoba: A retrospective cohort study ($17,850 for 1 year)
Emily Brownell, University of Manitoba, Rady Faculty of Health Sciences, Department of Community
Health Sciences (Medicine)
Program: 2022 Master’s Studentship
Funded By: Cost shared with Research Manitoba and Children’s Hospital Research Institute of Manitoba (CHRIM)
Project: First Nations women’s experiences with perinatal care in Northern Manitoba ($17,850 for 1 year)
HEALTH – BASIC BIOMEDICAL
Maria Astrid Bravo Jimenez, University of Manitoba, Rady Faculty of Health Sciences, Department of
Physiology and Pathophysiology (Medicine)
Program: 2022 Master’s Studentship
Funded By: 100% by Children’s Hospital Research Institute of Manitoba (CHRIM)
Project: Investigating the role of lysosomal activity and unfolded protein response in regulating
oligodendrocytes in multiple sclerosis ($17,850 for 1 year)
Maryana Kutuzova, University of Manitoba, Rady Faculty of Health Sciences, Department of Physiology
and Pathophysiology (Medicine)
Program: 2022 Master’s Studentship
Funded By: 100% by Children’s Hospital Research Ins�tute of Manitoba (CHRIM)
Project: Examining maternal and genetic influences on the development of diabetic kidney disease ($17,850 for 1 year)
PhD in Health Research Studentship Competition
SOCIAL/POPULATION HEALTH
Nicole Brunton, University of Manitoba, Rady Faculty of Health Sciences, Department of Pediatrics and Child Health (Medicine)
Program: 2022 PhD in Health Research Studentship
Funded By: 100% by Children’s Hospital Research Institute of Manitoba (CHRIM)
Project: Is exposure to diabetes in utero causally associated with hypertension in offspring? A
triangulation approach ($17,850 for 1 year)
Health Research Postdoctoral Fellowship Competition
SOCIAL/POPULATION HEALTH
Leah Crocke, University of Manitoba, Rady Faculty of Health Sciences, Department of Pediatrics andChild Health (Medicine)
Program: 2022 Health Research Postdoctoral Fellowship
Funded By: 100% by Children’s Hospital Research Institute of Manitoba (CHRIM)
Project Title: Implementing strategies to improve pediatric readiness in Manitoba Emergency Departments: a
randomized-control trial (RCT) ($44,100 for 1 year)
Tasmia Hai, University of Manitoba, Faculty of Arts, Department of Psychology
Program: 2022 Health Research Postdoctoral Fellowship
Funded By: 100% by Children’s Hospital Research Institute of Manitoba (CHRIM)
Project: Predictors of Self-Regulation skills and Externalizing Behaviours in Children participating in the BEAM Program ($44,100 for 1 year)
Congratulations to CHRIM Members who also received funding as part of the New Investigator Operating Grant Competition
Peter Thompson, University of Manitoba, Rady Faculty of Health Sciences, Department of Physiology and Pathophysiology (Medicine), CHRIM
Program: 2022 New Investigator Operating Grant
Project: Investigating immunotherapy and beta cell targeted approaches for treating Type 1
Diabetes ($130,000, over 2 years)
Deanna Santer, University of Manitoba, Rady Faculty of Health Sciences, Department of
Immunology (Medicine), CHRIM
Program: 2022 New Investigator Operating Grant
Project: Investigating the regulation of human adaptive immune responses by type III interferons ($129,134 , over 2 years)